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 In all kinds of cells, proteins are constantly synthesized while unnecessary 
proteins are simultaneously degraded and eliminated by various kinds of proteases. 
Protein degradation is important to eliminate damaged proteins, produce a pool of 
amino acids in response to starvation, and regulate cellular functions, immune response, 
and so on. If protein degradation system is dysregulated, damaged, oxidized or 
degenerated proteins accumulate inside the cells, which would be toxic for organisms 
and could cause various diseases. Thus, protein homeostasis is strictly regulated in a 
temporal and spatial manner to maintain cell survival, growth, and functions. 
 The ubiquitin-proteasome system plays a central role in degradation of 
intracellular proteins in eukaryotic cells. The 26S proteasome is a protease complex 
consisted of approximately 30 subunit proteins. Recognition of polyubiquitinated 
proteins by the 26S proteasome is considered as a key step in the selective degradation. 
The Rpn10 subunit of the 26S proteasome can bind to polyubiquitylated proteins via its 
ubiquitin-interacting motifs and plays a role in the interaction of the 26S proteasome 
with the substrates. Interestingly, it has been reported that there is structural diversity in 
Rpn10 subunits. Five distinct Rpn10 isoforms, Rpn10a, Rpn10b, Rpn10c, Rpn10d, and 
Rpn10e, are generated from a single gene by alternative splicing of mRNA in mouse. 
Since each Rpn10 isoform contains a unique C-terminal stretch, it is speculated that 
different Rpn10 isoform can interact with different proteins. However, it has been 
unclear whether such alternative splicing products are observed in other species than 
mice. In addition, it has been undetermined that each Rpn10 isoform plays 
isoform-specific function. 
 To elucidate the interspecies conservation of Rpn10 isoforms, I searched for 
Rpn10 cDNAs in databases and in my original PCR products from human, mouse, and 
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rat, in the first chapter. I also clarified the genomic organization of Rpn10 gene in lower 
vertebrates and provided evidence for the competent generation of distinct forms of 
Rpn10 by alternative splicing of mRNA through evolution. In the second chapter, I 
elucidated a specific function of one of the alternative-splicing products of Xenopus 
Rpn10, named Xrpn10c. I revealed that Xrpn10c functions as a specific receptor for 
Scythe that has been reported as an anti-apoptotic protein. My study showed that 
Xrpn10c has a Scythe-binding site at its C-terminal region and the forced expression of 
a Scythe mutant protein lacking Xrpn10c-binding domains in Xenopus embryos induces 
embryonic death, while the wild-type Scythe did not show any abnormality. These 
results from my studies indicate that Rpn10 family are largely conserved among 
vertebrates and may play an important role in the regulation of animal development 
probably via temporally controlled protein degradation. 
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ATP  adenosine triphosphate 
BAG  BCL2-associated athanogene 
BAT  human leukocyte antigen B (HLA-B)-associated transcript 
CHIP  C-terminus of Hsc70-interacting protein 
CS  conserved sequence 
DDBJ  DNA Data Bank of Japan 
DNA  deoxyribonucleic acid 
EMBL  European Molecular Biology Laboratory 
ER  endoplasmic reticulum 
ES  embryonic stem 
EST  expressed sequence tag 
FBS  fetal bovine serum 
FL  full-length 
GFP  green fluorescent protein 
GST  glutathione S-transferase 
HECT  homologous to the E6AP carboxyl terminus 
HR23  homologue of Rad23 
IFN  interferon 
IP  immunoprecipitation 
KI  knock-in 
KO  knockout 
LRR  leucine-rich-repeat 
PAGE  polyacrylamide gel electrophoresis 
PCR  polymerase chain reaction 
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PLIC  protein linking integrin-associated protein to cytoskeleton 
PUbS  polyubiquitin site 
RBR  ring between ring fingers 
RING  really interesting new gene 
RT  reverse transcription 
SDS  sodium dodecyl sulfate 
UBA  ubiquitin-associated 
UBL  ubiquitin-like 
UIM  uiquitin-interacting motif 
VWA  von Willebrand factor A 
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Ubiquitin-Proteasome System 
 
 Proteins are synthesized to maintain cell functions while damaged, degenerated, 
oxidized, or unnecessary proteins are simultaneously degraded in a timely manner. In 
other words, there is a balance between protein synthesis and protein degradation, and 
not only protein synthesis but protein degradation is indispensable for cells. Therefore, 
it is important to study how degradation of intracellular proteins is strictly regulated to 
maintain precise cellular functions. 
 The ubiquitin-proteasome system plays a crucial role in a temporal and spatial 
degradation of intracellular 
proteins in eukaryotic cells (Fig. 
1) (Coux et al., 1996). Ubiquitin 
is a small protein which consists 
of 76 amino acid residues. In the 
ubiquitin-proteasome system, 
ubiquitin covalently attaches to 
lysine residue(s) of target protein 
through its C-terminal glycine, 
changing the stability, function, 
or localization of the target 
protein (Haglund and Dikic, 
2005; Hershko and Ciechanover, 
1992). Ubiquitin also attaches to 
lysine residues of another ubiquitin 
Fig. 1. Ubiquitin-proteasome system 
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to form polyubiquitin chains. This post-translational modification of proteins is called 
ubiquitination or ubiquitylation. Ubiquitination is mediated by ubiquitin-activating 
enzymes (E1), ubiquitin-conjugating enzymes (E2), and ubiquitin ligases (E3). First, E1 
catalyzes the ATP-dependent activation of ubiquitin and formation of a thioester bond 
between ubiquitin C-terminus and the catalytic cysteine of the E1. Ubiquitin is then 
transferred to a catalytic cysteine of an E2 and through an E3 ligase to substrate proteins. 
Then, the 26S proteasome recognizes polyubiquitinated proteins as substrates and 
mediates selective protein degradation in an ATP-dependent manner (Hershko and 
Ciechanover, 1998). Collectively, the ubiquitin-proteasome system-mediated protein 
degradation comprises the two step reactions – the first step is the polyubiquitination of 
substrate proteins and the second step is the recognition and degradation of 
polyubiquitinated substrate proteins by the 26S proteasome. 
 The ubiquitin-proteasome system is highly conserved in eukaryotes. Many 
proteins implicated in various cellular functions have been reported to be broken down 
through this system. For instances, the ubiquitin-proteasome system is involved in 
control of cell cycle (Kawahara and Yokosawa, 1992; Yew, 2001), cell signaling (Lai, 
2002; Lohi and Lehto, 2001), stress response (Parag et al., 1987), endoplasmic 
reticulum (ER)-mediated protein quality control (Sommer and Wolf, 1997), apoptosis 
(Jesenberger and Jentsch, 2002; Tanaka and Kawahara, 2000), and immune response 
(Ben-Neriah, 2002). In addition, the ubiquitin-proteasome system is considered to 
contribute to various human diseases such as cancer, inflammation, and 
neurodegenerative diseases (Gong et al., 2016; Paul, 2008; Schwartz and Ciechanover, 
1999; Shen et al., 2013; Wang and Maldonado, 2006). 
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 As mentioned above, the ubiquitin-proteasome system recognizes various types 
of functional proteins as substrates. However, it has been reported that there are only 
two subtypes of E1 enzymes and fewer than 40 subtypes of E2 enzymes while E3 
consists of a large family of more than 600 proteins, suggesting that E3 ligases play an 
important role in the selection and recognition of substrate proteins to be degraded by 
the 26S proteasome (Deshaies and Joazeiro, 2009). The E3 ligase family is largely 
classified into two subfamily, HECT (homologous to the E6AP carboxyl terminus)-type 
E3 ligases (Zachariae and Nasmyth, 1999) and RING (really interesting new gene)-type 
E3 ligases (Jackson et al., 2000; Saurin et al., 1996). HECT-type E3 ligases and 
RING-type E3 ligases have distinct mechanisms of ubiquitin transfer to their substrate 
proteins. HECT-type E3 ligases catalyze ubiquitin transfer to the substrate protein 
through a two-step reactions; ubiquitin is first transferred to a catalytic cysteine of an E3 
and then from the E3 to the substrate. On the other hand, RING-type E3 ligases transfer 
ubiquitin directly to substrate proteins. In this respect, RING-type E3 ligases are more 
like scaffold proteins than enzymes. Some RING-type E3 ligases form a protein 
complex composed by multiple subunits with F-box proteins (e.g. Cullin and Skp-1). 
There are also small E3 ligase subfamilies called U-Box-type E3 ligases (Aravind and 
Koonin, 2000; Hatakeyama et al., 2001), which mediates a direct transfer of ubiquitin to 
the substrate, and RBR (ring between ring fingers)-type E3 ligases (Dove et al., 2016; 
Spratt et al., 2014) which catalyzes ubiquitin transfer through two-step reactions. Taken 
together, the heterogeneity of E3 ligases contributes to substrate specificity and dynamic 
regulation of intracellular protein degradation. 
 
Structure of 26S Proteasome 
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 The 26S proteasome is a protease complex consisted of approximately 30 
subunit proteins (Voges et al., 1999). The 26S proteasome is composed of two 
sub-complexes called the 20S proteolytic core complex (i.e. 20S proteasome) and the 
19S regulatory complex attached to the both ends of the 20S proteasome (Baumeister et 
al., 1998) (Fig. 2).  
 
 
 
 The subunits of the 20S proteasome are classified into seven alpha subunits and 
seven beta subunits based on the similarity in the primary structure. The 20S 
proteasome consists of four stacked rings composed of alpha/beta/beta/alpha subunits. 
Target proteins pass through the narrow pores of the alpha rings and then are degraded 
by proteolytic beta subunits located inside the beta rings. Among the seven beta 
subunits of the 20S proteasome, only three subunits – beta1, beta2, and beta5 - are 
proteolytically active and have N-terminal catalytic threonine residues. These 
Fig. 2. Structure of 26S proteasome 
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"constitutive" subunits are also replaced with interferon-γ (IFN-γ)-inducible subunits, 
beta1i (also called LMP2), beta2i (also called LMP7), and beta5i (also called MECL1), 
respectively, in the immunoproteasome which plays a role in antigen processing and 
other immunological functions (Fruh and Yang, 1999; Kimura et al., 2015; Tanaka and 
Kasahara, 1998). 
 The 19S regulatory complex consists of six ATPase subunits (Rpt1-6) and 
thirteen non-ATPase subunits (Rpn1-3, Rpn5-15) (Tanaka, 1998). The 19S regulatory 
complex is also divided into two subcomplexes called "base" and "lid" (Glickman et al., 
1998). The base complex consists of Rpt1-6, Rpn1, Rpn2, and Rpn13 while the lid 
complex consists of Rpn3, Rpn5-12, and Rpn15. The 19S regulatory complex plays a 
role in the regulation of proteasome function such as recognition of polyubiquitinated 
proteins, unfolding of target proteins, cleavage of polyubiquitin chains (i.e. isopeptidase 
activity), and regulation of the pores of the 20S proteasome (Ferrell et al., 2000). 
However, functions of each subunit have not been fully clarified. It has been also still 
unclear how the 26S proteasome recognizes various target proteins to degrade in a 
temporal and spatial manner. 
 
Functions and structure of Rpn10 
 
 Rpn10 is localized at the intermediate of the lid and the base complexes in the 
19S regulatory complex and has been reported to be implicated in the recognition of 
polyubiquitinated proteins. Its N-terminal von Willebrand factor A (VWA) domain is 
considered to play a role in the interaction of those complexes (Fig. 3) (Glickman et al., 
1998). On the other hand, its C-terminal region contains one or two polyubiquitin sites 
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Fig. 3. Localization of Rpn10 
(PUbS). Each PUbS contains a ubiquitin-interacting 
motif (UIM) which strongly binds with tetra or longer 
ubiquitin chains (Hofmann and Falquet, 2001). The 
UIMs consist of approximately 20 amino acids and 
contain a consensus sequence motif, 
xEDExLxxAxxxSxxExxxx (x is an arbitrary amino 
acid residue). It is considered that the bulky 
hydrophobic amino acid residues, acidic amino acid residues, and serine residue are 
important for the interaction of Rpn10 with polyubiquitin chains. A UIM was originally 
identified from Rpn10, but it has been found that other proteins, especially lysosomal 
proteolytic proteins, also have UIMs (Hofmann and Falquet, 2001). Although it is 
unknown if all the proteins containing UIMs could bind with polyubiquitin chains, it 
has been well validated that Rpn10 binds with polyubiquitinated proteins. Thus, Rpn10 
is considered to be a ubiquitin receptor in the 26S proteasome. 
 Rpn10 orthologues have been identified to date in various organisms such as 
yeast, nematodes, fruit fries, vertebrates, and plants. They are also called Mcb1 in the 
moss Physcimitrella patens (Girod et al., 1999), Sun1 in the budding yeast 
Saccharomyces cerevisiae (van Nocker et al., 1996b), Pus1 in the fission yeast 
Schizosaccharomyces pombe (Wilkinson et al., 2000), Mbp1 in the grass plant 
Arabidopsis thaliana) (Deveraux et al., 1995), p-54 in the fruit fly Drosophila 
melanogaster (Haracska and Udvardy, 1995), and S5a in Homo sapiens (Ferrell et al., 
1996), respectively. The structures and amino acid sequences of their N-terminal VWA 
domains are highly conserved. In yeast, Rpn10 (Sun1) was originally identified as one 
of the two multi-copy suppressors of nin1-1 (the Rpn12 lethal mutation) (Kominami et 
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al., 1997). This effect was observed not only with the full length of Rpn10 but with the 
N-terminal 200 amino acids of Rpn10 (i.e. ∆PUbS mutant). These results suggest that 
Rpn10 plays an important role in construction of the 19S regulatory complex through its 
N-terminal region, interacting with other proteasome subunits and ligating the lid and 
the base complexes. In this regard, Rpn10 has been considered to interact with Rpn1 
from the base complex and Rpn9, Rpn11, or Rpn12 from the lid complex (Ferrell et al., 
2000). Moreover, a conserved-aspartate residue (Asp11) at the VWA domain of Rpn10 
plays an important role in the formation of the 26S proteasome and it is known that a 
point-mutation of this amino acid results in disruption of the 26S proteasome (Fu et al., 
2001). 
 In yeast, it has been reported that Rpn10 deficiency does not lead to lethality 
but exhibits enhanced sensitivity to amino acid analogues and has increased steady-state 
levels of ubiquitin-protein conjugates (van Nocker et al., 1996b; Wilkinson et al., 2000). 
Interestingly, this phenotype was rescued by expression of an Rpn10 mutant protein that 
lacks the UIM, suggesting that the C-terminal PUbS of yeast Rpn10 is dispensable and 
redundant for survival and the stress responses. On the other hand, P. patens Rpn10 
(Mcb1) knockout (KO) strain suppressed its growth at early development and thus 
Mcb1 is found essential for normal growth (Girod et al., 1999). Interestingly, its 
N-terminal mutant caused more severe phenotype than its C-terminal mutant, 
suggesting the N-terminal domains of Rpn10 are important in yeast. This, however, may 
not be the case for vertebrate cells because the C-terminal structure of vertebrate Rpn10 
is different from that of those organisms. 
 Most of the 26S proteasome subunits have highly-conserved structures among 
eukaryotes. However, the C-terminal structures of Rpn10 are largely different between 
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Fig. 4. Schematic structures of mouse Rpn10 (Mrpn10) family 
yeast and other organisms in the opisthokonta lineage. Yeast Rpn10 contains only one 
PUbS in the C-terminal region (van Nocker et al., 1996b; Wilkinson et al., 2000) while 
Rpn10 from other organisms generally contains two PUbS and other unique domain(s). 
This fact may suggest that Rpn10 acquired new functions in the extended C-terminal 
domains in the course of evolution in the opisthokonta lineage. For example, each PUbS 
in human Rpn10 contains a UIM but these two UIMs are not functionally identical; the 
UIM2 binds more strongly with polyubiquitin chains than the UIM1 in vitro (Young et 
al., 1998). Moreover, the human homolog of Rad23B (HR23B), a ubiquitin-like protein 
(UBL), has been reported to interact with PUbS2 but not with PUbS1 of human Rpn10 
(S5a) (Hiyama et al., 1999). These results indicate distinct roles of two PUbS of Rpn10 
in the recognition of polyubiquitinated target proteins and other functional proteins. 
Taken together, Rpn10 can interact with a wide variety of proteins and is considered to 
play various roles. 
  Kawahara et al. have identified five Rpn10 isoforms, Rpn10a, Rpn10b, Rpn10c, 
Rpn10d, and Rpn10e from Mus musculus (Fig. 4) (Kawahara et al., 2000a). All of them 
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are generated by alternative splicing of the introns of 3' regions of the sole gene. All the 
isoforms have the same N-terminal region but each isoform contains a distinct and 
unique structure in the C-terminal stretch. It has been speculated that Rpn10a is 
constitutively expressed and the others are highly expressed in mouse embryo. Rpn10e 
is a unique isoform in that its structure is similar to yeast Rpn10 and its expression 
reaches the peak in the embryonic brain at late development stages. Thus, it is 
speculated that there may be different types of the 26S proteasome which contain 
different Rpn10 isoforms, depending on developmental stages, possibly playing a role 
in proteolysis of different types of proteins. The specific function of each Rpn10 
isoform, however, has been almost unknown to date. It has been also totally unknown if 
other species than mice and humans have a variety of Rpn10 splicing isoforms. 
 
Objective of my studies 
 
 To shed the light on the significance of Rpn10 isoforms, I studied genomic 
organization of Rpn10 gene from various organisms including nematodes, fish, and 
frogs in the first chapter. In addition, to clarify the role of an Rpn10 isoform in the 26S 
proteasome, I focused on Xenopus Rpn10c, identified a specific interacting-protein, and 
investigated its physiological role in the Xenopus development in the second chapter.  
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Chapter 1: 
The 26S Proteasome Rpn10 Gene Encoding Splicing Isoforms: Evolutional 
Conservation of the Genomic Organization in Vertebrates 
  
21 
 
Abstract 
 
 Recognition of polyubiquitinated substrates by the 26S proteasome is a key 
step in the selective degradation of various cellular proteins. The Rpn10 subunit of the 
26S proteasome can bind to polyubiquitin conjugates in vitro. Kawahara et al (2000a). 
previously reported the unique diversity of Rpn10, which differs from other multiple 
proteasome subunits, and that the mouse Rpn10 mRNA family is generated from a 
single gene by developmentally-regulated alternative splicing. To determine whether 
such alternative splicing mechanisms occur in other species, I searched for Rpn10 
isoforms in databases and in my original PCR products.  
 Here I report the genomic organization of Rpn10 gene in lower vertebrates and 
provide evidence for the competent generation of distinct forms of Rpn10 by alternative 
splicing through evolution. My results suggested that the diversity of Rpn10 caused by 
alternative splicing has been acquired during the course of vertebrate evolution, or that 
such splicing potential was abandoned in invertebrates.  
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Introduction 
 
 Ubiquitin is a covalent modifier that produces a polyubiquitin chain acting as a 
selective degradation signal (Coux et al., 1996; Hershko and Ciechanover, 1998; 
Hochstrasser, 1996). Protein ubiquitination is catalyzed by a multi-enzymatic system 
consisting of E1 (ubiquitin-activating), E2 (ubiquitin-conjugating), and E3 
(ubiquitin-ligating) enzymes. Most E3 enzymes directly bind to target proteins in a 
substrate-specific manner, in a process designed to select proteins for degradation 
(Hershko and Ciechanover, 1998). There is ample evidence in support of the critical role 
of the ubiquitin pathway in a variety of biologically important processes, including 
cell-cycle control, apoptosis, signal transduction, development, and immune response 
(Hershko and Ciechanover, 1998; Kawahara et al., 2000b; Kawahara and Yokosawa, 
1992; Kornitzer and Ciechanover, 2000; Schwartz and Ciechanover, 1999; Tanaka and 
Kasahara, 1998; Tanaka and Kawahara, 2000).  
 Degradation of polyubiquitinated proteins is catalyzed by the 26S proteasome, 
a eukaryotic ATP-dependent protease complex (Voges et al., 1999). The 26S proteasome 
is composed of a core proteinase complex, known as the 20S proteasome (Bochtler et 
al., 1999), and a pair of symmetrically disposed PA700 regulatory particles (alias the 
19S complexes) (Baumeister et al., 1998; Coux et al., 1996; Ferrell et al., 2000; 
Kanayama et al., 1992). PA700 is attached to both ends of the central 20S proteasome in 
opposite orientations to form the enzymatically active 26S proteasome in an 
ATP-dependent manner (DeMartino and Slaughter, 1999; Tanahashi et al., 1999).  
 PA700 was discovered as an activator of the 20S proteasome (DeMartino et al., 
1996; DeMartino and Slaughter, 1999). It is a 700-kDa protein complex composed of 
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~20 subunits each ranging in size from 25 to 110 kDa (DeMartino and Slaughter, 1999; 
Tanaka, 1998). PA700 consists of two subcomplexes, known as “base” and “lid”, which, 
in the 26S proteasome, correspond to the portions of PA700 proximal and distal, 
respectively, to the 20S proteasome (Glickman et al., 1998). The base is comprised of 
six ATPases and two largest regulatory components named Rpn1 and Rpn2, while the 
lid contains multiple non-ATPase subunits. The base-complex, thought to bind to the 
outer α-ring of the central 20S proteasome ATP-dependently, is thought to be involved 
in opening the gate of the α-ring for entry of the protein substrate, as well as 
chaperon-like activity toward substrates for unfolding, so substrates can be penetrated 
into a chamber formed by the β-ring where the active sites are located (Braun et al., 
1999). On the other hand, the lid-complex is thought to be required for recognition of 
target proteins. The lid- and base-complexes assemble to form the regulator complex 
PA700 through multiple subunit interactions (Fu et al., 2001; Glickman et al., 1998). 
 Recognition of polyubiquitinated substrates by the 26S proteasome is a key 
step for the selective degradation of various cellular proteins. Previous studies showed 
that the Rpn10 subunit of human PA700, originally called S5a, can bind to a 
polyubiquitin chain linked to proteins in vitro (Deveraux et al., 1994; Deveraux et al., 
1995). Moreover, deletional analyses of Rpn10 revealed that there are at least two 
independent polyubiquitin binding sites, named UIM1 and UIM2 (also called PUbS1 
and PUbS2, respectively), in the carboxyl terminal half of human Rpn10 (Fu et al., 
1998; Haracska and Udvardy, 1997; Hofmann and Falquet, 2001; Young et al., 1998). 
Although only one segment (i.e., UIM1) appears to be sufficient for the polyubiquitin 
chain-binding activity as seen in yeast Rpn10 or the segment artificially produced from 
Rpn10 of other organisms (Fu et al., 1998; Girod et al., 1999; Haracska and Udvardy, 
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1997), the co-existence of UIM2 increases apparent affinity for polyubiquitin chains, 
indicating that both UIM1 and UIM2 act in concert for polyubiquitin recognition in 
vitro (Young et al., 1998). In mammals, both UIM1 and UIM2 are approximately 
30-amino acid long and are separated by 21 intervening amino acid residues (Young et 
al., 1998). It is interesting to note that the length between two UIM motives is strictly 
conserved in vertebrates, although amino acid sequences of the intervening regions are 
not strongly conserved, unlike the high conservation in these UIM regions. 
 Rpn10 homologues have been identified in various eukaryotes, such as yeast 
(Kominami et al., 1997; van Nocker et al., 1996b), plant (van Nocker et al., 1996a), fruit 
fly (Haracska and Udvardy, 1995), moss (Girod et al., 1999), fish (Yanagawa et al., 
1998), mice (Kawahara et al., 2000a; Pusch et al., 1998), and humans (Ferrell et al., 
1996), and are given various names; such as Mcb1, Sun1, Mbp1, p-54 and S5a. 
Curiously, the size of Rpn10 is exceptionally small in only the yeast protein lacking the 
C-terminal region beyond the UIM1 domain (Fig. 5) (Kominami et al., 1997; van 
Nocker et al., 1996b), indicating that the C-terminal additional domains including UIM2 
and KEKE, a domain enriched in alternating Lys and Glu (Realini et al., 1994), have 
been acquired in multicellular organisms or abandoned in yeast during evolution in the 
opisthokonta lineage. 
 As reported previously, the mouse Rpn10 mRNA family is generated from a 
single gene by developmentally-regulated alternative splicing (Fig. 6) (Kawahara et al., 
2000a). Mouse Rpn10 gene is about 10 kbp-long, which is comprised of 10 exons, and 
specific sequences of variant Rpn10 family-proteins are encoded in intronic regions of 
the Rpn10a gene present ubiquitously in all cells (Kawahara et al., 2000a). However, it 
has been unknown whether Rpn10 family-proteins exist in other species than mice. 
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 In this chapter, I sought to clarify genomic organization of Rpn10 gene from 
various organisms and determined the genomic sequences encoding Rpn10 from 
nematodes, fish and frogs. Comparison of the genomic and cDNA sequences of Rpn10 
revealed similar gene organizations from lower vertebrates to human, suggesting 
potential existence of Rpn10 isoforms in vertebrates, although actual splicing products 
have not been cloned from other vertebrates than mammals. Taken together, 
highly-conserved Rpn10 genomic structure in vertebrates suggests its significant and 
the fundamental role of the Rpn10 family. 
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Materials and Methods 
 
Determination of Rpn10 gene sequences of Oryzias latipes and Xenopus laevis 
 First, the partial sequences of the coding regions of the Rpn10 genes were 
amplified by degenerated PCR from O. latipes ovary cDNA libraries and X. lavis cDNA 
libraries prepared from embryos using Takara Ex Taq (Takara Bio Inc.) The primer 
sequences used in the experiments were 5'-CTGGCTTTGCGTGT(G/C)TCIATG-3' and 
5'-GTTCTCAAGCACICT(T/C)TG-3' for O. latipes and 
5'-CTGGCTTTGCGTGT(G/C)TCIATG-3' and 5'-GATTCTCCAGGACICT(T/C)TG-3 
for X. laevis. Next, the 5'-terminal and 3'-terminal of the Rpn10 genes were amplified by 
nested PCR. The PCR primer sequences used for Oryzias latipes Rpn10 were 
5'-CTGGCTTTGCGTGTGTCGATG-3' and 5'-AATTAACCCTCACTAAAGGG-3' for 
the first PCR for the 5'-terminal sequences, 5'-AAGACGCCCTGTTGAAGATG-3' and 
5'-CGCTCTAGAACTAGTGGATC-3' for the second PCR for the 5'-terminal sequences, 
5'-CCTGCATCACATCGTAGTCG-3'  and 5'-GTAAAACGACGGCCAGT-3' for the 
first PCR for the 3'-terminal sequences, 5'-ATCTGCTCCTCCTCGGTCAT-3' and 
5'-TCGAGGTCGACGGTATC-3' for the second PCR for the 3'-terminal sequences. The 
PCR primer sequences used for X. laevis Rpn10 were 
5'-CTGGCTTTGCGTGTGTCGATG-3' and 5'-AATTAACCCTCACTAAAGGG-3' for 
the first PCR for the 5'-terminal sequences, 5'-GGAGGAGCAGAGGCAGCGGCA-3' 
and 5'-CGCTCTAGAACTAGTGGATC-3' for the second PCR for the 5'-terminal 
sequences, 5'-ATTCTCCAGGACGCTCTGTAA-3' and 
5'-GTAAAACGACGGCCAGT-3' for the first PCR for the 3'-terminal sequences, 
5'-AAGAACTCGGGGTCCTGCATC-3' and 5'-TCGAGGTCGACGGTATC-3' for the 
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second PCR for the 3'-terminal sequences. Finally, the whole sequences of Rpn10 
genome and Rpn10a cDNA were amplified by PCR from the cDNA libraries described 
above, O. latipes genome DNA libraries or X. genomic DNA prepared from testis. The 
PCR primer sequences were 5'-ATGGTGCTTGAAAGTACTAT-3' and 
5'-TCACTTTTTTTTCTCCTCTT-3' for O. latipes Rpn10, and 
5'-ATGGGGCTGGAAAGTACTAT-3' and 5'-TCATTTCTTCTCCTCCTTCTT-3' for X. 
laevis Rpn10. Amplified PCR products were cloned into pGEM-T Easy Vector 
(Promega Inc.) Sequencing reactions used T7 and Sp6 primers and ABI BigDye version 
2.0 chemistry (Applied Biosystems). Sequences were determined using an ABI PRISM 
377 Genetic Analyzer. 
 Human and rat Rpn10 isoforms were identified based on the expressed 
sequence tag (EST) sequences found from the NCBI Nucleotide Database 
(https://www.ncbi.nlm.nih.gov/nuccore) by using the amino acid sequences of mouse 
Rpn10 isoforms as a query.   
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Results 
 
 To determine whether alternative splicing of Rpn10 could have occurred in 
other species than mice, I searched for the existence of Rpn10 isoform transcripts in the 
EST database and applied PCR amplification in my analysis. My studies identified the 
existence of homologous splice variants not only in mice but also in other mammals 
including humans and rats (Table 1). These genes contain homologous sequences 
specific for each Rpn10 family, which are spliced at exactly the same position of the 
gene, suggesting that these mRNAs for the Rpn10 family in each species are generated 
by a universal mechanism, at least in mammals. In accordance with this observation, the 
genomic structures of mouse and human Rpn10 genes are quite identical, although the 
length of introns is somewhat diverse. In contrast, so far I have not found any Rpn10 
isoforms in EST databases of non-vertebrate species. To compare the organizations of 
invertebrate Rpn10 genes with those of the vertebrates, I searched the public database 
for genomic sequences. The available genomic databases revealed the lack of intronic 
sequences in the region corresponding to the C-terminal half in nematode, 
Caenorhabditis elegans, and fruit fly, Drosophila melanogaster, strongly indicating that 
any Rpn10-splicing isoforms are not produced in these organisms (Fig. 5). This means 
that the diversity of Rpn10 caused by alternative splicing has been acquired during the 
course of vertebrate evolution, or that such splicing potential was abandoned in 
invertebrates. 
 To determine whether alternative splicing of Rpn10 is specific to mammals, I 
isolated and determined the sequence of genomic clones and cDNA clones encoding 
Rpn10 from Japanese rice fish, O. latipes, as an example of the lower vertebrates. 
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Comparison of the genomic and cDNA sequences of Rpn10 revealed similar gene 
organizations extending from the fish to human (Fig. 5 and 6). The positions of the 
exon-intron junctions and the length of each exon are also completely conserved among 
vertebrates Rpn10 genes (Fig. 5). This finding implies that the competence for all 
distinct forms of Rpn10 alternative splicing is widely retained in vertebrates. Although 
actual splicing products have not yet been reported to date, my results indicate that 
some of the Rpn10 isoforms are in fact expressed in lower vertebrates (shown and 
discussed in the next chapter). In considering the fact that mouse Rpn10 mRNA family 
is generated from a single gene by developmentally regulated, alternative splicing 
(Kawahara et al., 2000a), the strong conservation of Rpn10 genomic structure in diverse 
vertebrates indicates its significant and the fundamental role of the Rpn10 family in the 
development of vertebrates. 
  
30 
 
Discussion 
 
 In general, almost all proteasome subunits are highly conserved in eukaryotes 
(Tanaka, 1998). However, recent studies have shown that certain proteasome genes have 
been acquired or diverged around an era close to the origin of vertebrates. For example, 
it is known that a major immunomodulatory cytokine IFN-γ induces replacement of 
three constitutive β-type subunits of the 20S proteasome by IFN-γ-inducible subunits, 
thereby producing “immunoproteasomes” responsible for immunological processing of 
intracellular antigens, which play a critical role in adaptive immunity (Tanaka and 
Kasahara, 1998). Furthermore, IFN-γ also induces a proteasome activator known as 
PA28, REG or the 11S regulator, consisting of two related subunits, α and β, which 
appears to be involved in the accelerating processing of certain antigens (DeMartino and 
Slaughter, 1999; Hendil et al., 1998; Murata et al., 1999; Rechsteiner et al., 2000; 
Tanaka and Kasahara, 1998). Naturally the genome of yeast lacking immunity does not 
contain genes coding for IFN-γ-inducible genes. These genes all appear to have 
emerged close to the origin of vertebrates to accommodate the needs for production of 
antigenic peptides capable of binding efficiently to major histocompatibility complex 
class I molecules (Tanaka and Kasahara, 1998). Likewise, the existence of multiple 
forms of Rpn10 in mammals and perhaps other vertebrates, but the apparent absence of 
Rpn10 splice variants in invertebrates, may represent another example of adaptive 
changes in evolution, indicating that Rpn10 has species-specific functions in higher 
eukaryotes.  
 The alteration of structural complexities in the Rpn10 subunit is presumably 
responsible for acquisition of its functional changes. Intriguingly, it has been 
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documented that human Rpn10a interacts directly with various other proteins. For 
example, the Ub-like domain of hHR23 (the human homologue of yeast Rad23) can 
interact directly with the region of UIM2 in the C-terminal half of Rpn10a (Hiyama et 
al., 1999). Thus, the evolutionarily acquired C-terminal diversity of the Rpn10 family 
expands the possibility of Rpn10-mediated interactions of potential proteasome 
substrates and proteolytic regulators. Therefore, it is not surprising that the phenotypes 
of Rpn10 deficiency in several organisms are rather inconsistent depending on species. 
Indeed, disruption of the gene orthologous to Rpn10 (rpn10) did not cause any obvious 
defects in yeast (Kominami et al., 1997; van Nocker et al., 1996b), but intriguingly 
Rpn10 suppression induced meiotic arrest and an F2 sterile phenotype in C. elegans 
(Shimada et al., 2006), and gene knockout (KO) of Rpn10 by homologous 
recombination was associated with fetal death in mice (Hamazaki et al., 2007). Thus, 
unlike the situation in yeast, Rpn10 appears to play a more important role in 
reproduction and embryonic development in other eukaryotes.  
 One fundamental function of Rpn10 is assistance in establishing a linkage 
between the base and lid complex, and formation of the stable 19S complex (Glickman 
et al., 1998). In addition, the polyubiquitin binding ability by UIM1 domain in the 
Rpn10 protein is thought to be redundant rather than essential (Fu et al., 1998). In 
considering evolution of the RPN10 gene to vertebrates, my favorite scenario is that the 
Rpn10 molecule has acquired or retained its C-terminal extension and complexities 
generated by the mechanism of alternative splicing, which meets the requirement for 
expanded diversity of ubiquitin-mediated protein degradation. Further functional 
analyses of Rpn10 isoforms are needed to determine the significance of complexities of 
the Rpn10 family. Clarification of the substrate-recognition diversity by the Rpn10 
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family will be a future prospect. 
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Tables and Figures 
 
Table 1. Mammalian Rpn10 isoforms.  
 
 Rpn10a Rpn10b Rpn10c Rpn10d Rpn10e 
Mouse NM008951 AW541266 AA060854 AB029145 BI687156 
Rat AF175575 AB017188 AI236731 ND Direct cloning 
Human U72664 AL570579 BI006619 ND AB033605 
 
These Rpn10 variants shown by EST accession numbers are found in the EST database. 
Some isoforms were identified by my RT-PCR-based amplification techniques. ND, not 
determined. 
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Fig. 5. Schematic representation of Rpn10 protein structures of various 
evolutionary distinct species.  
The positions of introns in their corresponding genome sequences are marked as 
indicated by the symbol. The polyubiquitin-binding domains (UIM1 and UIM2), 
C-terminal highly conserved sequence (CS) and the KEKE domain are boxed as 
indicated by filled designs. Yeast, Saccharomyces cereviciae, Schizosaccharomyces 
pombe; nematode, Caenorhabditis elegans; fruit fly, Drosophila melanogaster; Japanese 
rice fish, Oryzias latipes; mouse, Mus musculus; and human, Homo sapiens. 
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Fig. 6. Physical maps of genomic organization of yeast, nematode, fish and mouse 
Rpn10 genes.  
The scale shows the length of 1 kbp. Exons are indicated by solid boxes and numbered 
from 1 to 10. The structures of the mouse multiple Rpn10 transcripts generated by 
alternative splicing are shown schematically at the bottom of the figure. 
Protein-encoding regions are represented by boxes and introns by lines. Solid boxes: 
UIM1, UIM2 or Rpn10c-specific regions, as specifically indicated. Open boxes: 
less-conserved regions. 
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Chapter 2: 
Unique Proteasome Subunit Xrpn10c Is a Specific Receptor for the 
Antiapoptotic Ubiquitin-like Protein Scythe 
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Abstract 
 
 The Rpn10 subunit of the 26S proteasome can bind to polyubiquitylated and/or 
ubiquitin-like proteins via the ubiquitin-interacting motifs (UIMs). The vertebrate 
Rpn10 consists of five distinct spliced isoforms, but the specific function of these 
variants remains largely unknown. I demonstrated that one of the alternative products of 
Xenopus Rpn10, named Xrpn10c, functions as a specific receptor for Scythe/BAG-6 
that has been reported to regulate Reaper-induced apoptosis. Deletional analyses 
revealed that Scythe has at least two distinct domains responsible for its binding to 
Xrpn10c. Conversely, an Xrpn10c has an UIM-independent Scythe binding site. The 
forced expression of a Scythe mutant protein lacking Xrpn10c-binding domains in 
Xenopus embryos induces inappropriate embryonic death, while the wild-type Scythe 
did not show any abnormality. These results indicate that Xrpn10c-binding sites of 
Scythe act as an essential segment linking the ubiquitin/proteasome machinery to the 
control of proper embryonic development. 
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Introduction 
 
 Ubiquitin is a covalent modifier that produces a polyubiquitin chain that 
functions as a degradation signal (Finley et al., 2004; Hershko and Ciechanover, 1998; 
Hershko et al., 2000; Schwartz and Hochstrasser, 2003). Degradation of 
polyubiquitylated proteins is catalyzed by the 26S proteasome, a eukaryotic 
ATP-dependent protease complex (Baumeister et al., 1998; Coux et al., 1996; 
DeMartino and Slaughter, 1999; Voges et al., 1999). The 26S proteasome is composed 
of the catalytic 20S proteasome and a regulatory complex termed PA700 or 19S 
complex. PA700 is a 700-kDa protein complex composed of six ATPase subunits 
(Rpt1-6) and multiple non-ATPase subunits (Rpn1-3, Rpn5-15), each ranging in size 
from 11 to 110 kDa (DeMartino and Slaughter, 1999; Tanaka, 1998). 
 Recognition of polyubiquitylated substrates by the 26S proteasome is a key 
step in the selective degradation of various cellular proteins (Pickart, 1997; Pickart and 
Cohen, 2004; Szlanka et al., 2003). Previous studies have shown that several 
ubiquitin-associated (UBA) domain proteins and the Rpn10 subunit of 26S proteasome, 
originally called S5a, can bind to a polyubiquitin chain linked to proteins in vitro 
(Elsasser et al., 2004; Ferrell et al., 1996; Haracska and Udvardy, 1997; van Nocker et 
al., 1996b; Verma et al., 2004; Wilkinson et al., 2001). A deletional analysis of Rpn10 
revealed that there are at least two independent polyubiquitin-binding sites, named 
UIM1 (PUbS1) and UIM2 (PUbS2), in the C- terminal half of vertebrate Rpn10 
(Hofmann and Falquet, 2001; Young et al., 1998). Although only one segment (i.e., 
UIM1) appears to be sufficient for polyubiquitin chain-binding activity as was found in 
yeast Rpn10 (Beal et al., 1998; Elsasser et al., 2004; van Nocker et al., 1996b), the 
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co-existence of UIM2 increases the affinity for binding of polyubiquitin chains, 
indicating that both UIM1 and UIM2 act in concert for polyubiquitin recognition in 
vitro (Young et al., 1998). In addition to polyubiquitin chain binding, it has been shown 
that UIM2 of human Rpn10 interacts with several ubiquitin-like (UBL) proteins via 
their UBL domains. For example, the UBL domains of hHR23B (the human homologue 
of yeast Rad23) and PLIC (the human homologue of yeast Dsk2) can directly interact 
with human Rpn10 (Hiyama et al., 1999; Schauber et al., 1998; Walters et al., 2002). 
Thus, mammalian Rpn10 is thought to be one of the recognition sites for several UBL 
proteins, as well as for polyubiquitin chains. 
 It was previously reported that the mouse rpn10 mRNA family is generated 
from a single gene by developmentally-regulated alternative splicing, producing 
Rpn10a to Rpn10e (Kawahara et al., 2000a). The mouse rpn10 gene is about 10 kbp 
long and is composed of 10 exons, and it has been found that specific sequences of 
variant Rpn10 family proteins are encoded in the intronic regions of the rpn10a gene, 
suggesting that the repertoire of the mouse rpn10 mRNA family is regulated at the 
post-transcriptional level (Kawahara et al., 2000a). Rpn10a is an ortholog of human S5a 
(Haracska and Udvardy, 1997) and is ubiquitously expressed during development, while 
Rpn10c is specifically expressed in mouse embryonic tissues and at particularly high 
levels in ES cells (Carter et al., 2003; Kawahara et al., 2000a). Rpn10c contains two 
UIM domains as is the case with Rpn10a, but it also contains a unique sequence in its 
C-terminal region differing from any other proteins including other Rpn10 isoforms. 
However, apart from its characteristic expression pattern, the role of Rpn10c is not 
known at present.  
42 
 
 Apoptosis is a form of cell death and is essential for the correct development 
and homeostasis of multicellular organisms (Chinnaiyan and Dixit, 1996; Hensey and 
Gautier, 1998; Stack and Newport, 1997). A potent apoptotic inducer, Reaper, is critical 
for programmed cell death in the fruit fly Drosophila melanogaster (White et al., 1994). 
Although Reaper homologues in other species have not yet been reported, it has been 
shown that ectopic expression of Reaper in human cells and in Xenopus cell-free 
extracts can also trigger apoptosis, suggesting that Reaper-responsive pathways are 
conserved (Thress et al., 1999; Thress et al., 1998). Thress et al. (1998) identified a 
150-kDa protein as the Reaper-binding molecule in Xenopus egg extracts and 
designated this protein as Scythe (Thress et al., 1998). It has been reported that Scythe 
contains a BAG domain as a chaperone-binding region in its C-terminal region (and 
thereby also called BAG-6) and a single UBL domain in its N-terminal region, but the 
function of the latter domain remains completely elusive to date.  
 To investigate the function of the Rpn10c subunit of 26S proteasomes, I cloned 
the Xenopus counterpart of mouse Rpn10c cDNA and named the gene xrpn10c. Here I 
report that Xrpn10c protein is a specific receptor of Scythe/BAG-6. I found that an 
Xrpn10c-specific C-terminal sequence is required and sufficient for Scythe binding. 
Conversely, I identified novel tandem domains in the N-terminal region of Scythe and 
found that these domains are necessary for Xrpn10c binding. I also found that forced 
expression of a Scythe mutant lacking Xrpn10c-binding sites induced inappropriate 
embryonic development. These findings provide the first evidence that N-terminal 
tandem domains of Scythe act as essential regions linking the ubiquitin/proteasome 
machinery to the control of Xenopus embryonic development. 
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Materials and Methods 
 
Plasmid construction 
 The full-length cDNAs of Xrpn10a, Xrpn10c and Scythe were amplified by 
PCR from Xenopus cDNA libraries prepared from stage 25 embryos. To generate a 
series of Xrpn10 expression vectors, PCR products were cloned into the pCR2.1 vector, 
respectively (Invitrogen, San Diego, CA). After digestion with EcoRI and SalI, each 
xrpn10 isoform gene was inserted into the pCI-neo-Flag mammalian expression vector 
(Promega, Madison, WI). Similarly, the PCR products of Scythe subcloned into the 
pCR2.1 vector were digested with SalI and NotI and inserted into the pCI-neo-T7 vector. 
The truncated and mutated versions of Xrpn10 and Scythe were constructed by PCR 
with pCI-neo vectors as templates using a forward primer and mutated reverse primers. 
The Xrpn10 (N5) mutants were generated using a QuickChange Site-Directed 
Mutagenesis kit (Stratagene, La Jolla, CA) and subcloned into the pCI-neo-Flag vector. 
The GFP-fused expression vectors of Xrpn10 were constructed by digesting 
pCI-neo-T7-Xrpn10 with EcoRI and SalI, and the resulting fragment was subcloned 
into pEGFP-C2 (Clontech Laboratories, Palo Alto, CA). Sequences of all plasmids were 
verified before transfection experiments. 
 
Immunoprecipitation and immunoblotting 
 COS7 cells (monkey kidney cell line) were transiently transfected with the 
indicated plasmids using FuGENE6 (Roche Molecular Systems, Inc., NJ) according to 
the protocol supplied by the manufacture. The total amount of plasmid DNA was 
adjusted to 1 µg with an empty vector. After incubation for 36 h, the cells were 
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harvested and subjected to immunoprecipitation and/or Western blot analyses. After the 
cells had been washed with ice-cold PBS, they were lysed with a buffer containing 50 
mM Tris-HCl, pH 7.5, 0.3 M NaCl, 0.5% Triton X-100, complete protease inhibitor 
cocktail (Roche), 10 mM N-ethylmaleimide and 50 µM MG132 (Peptide Institute Inc. 
Tokyo, Japan). The cell lysate was sonicated for 10 seconds, and the debris was 
removed by centrifugation at 13,000 × g for 20 min. The resulting supernatant was 
incubated with anti-Flag M2 affinity gel (Sigma Chemical Co., St. Louis, MO) for 2 h at 
4°C, and the immunocomplex produced was washed five times with lysis buffer. 
Immunoprecipitation of the 26S proteasome was conducted using an antibody specific 
for the Rpt6 ATPase subunit of the human 26S proteasome (Hendil et al., 1998) and 
Protein A-Sepharose 4B (Amersham Biosciences, Uppsala, Sweden). 
 For Western blotting, the whole cell lysate and immunoprecipitates were 
separated by SDS-PAGE and transferred onto nitrocellulose membranes (Bio-Rad, 
Richmond, CA). The membranes were immunoblotted with anti-T7 (Novagen, Madison, 
WI), anti-Myc (9E10, Santa Cruz Biotechnology, Santa Cruz, CA), anti-Flag M2 
(Sigma) and anti-green fluorescent protein (Clontech) antibodies and then incubated 
with horseradish peroxidase-conjugated antibody against mouse or rabbit 
immunoglobulin (Amersham Biosciences, Buckinghamshire, UK), followed by 
detection with ECL Western blotting detection reagents (Amersham Biosciences, UK). 
  
GST pull-down assay 
 For expressing GST-fusion proteins, all genes were subcloned into the 
pGEX6P1 vector (Amersham Pharmacia) and transformed into E. coli BL21 (DE3). 
GST-fusion proteins were expressed in E. coli, and the extracts were applied to 
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glutathione-immobilized agarose beads (Amersham Pharmacia) and eluted with 50 mM 
glutathione in 50 mM Tris-HCl, pH 8.0. The eluted proteins were then dialyzed against 
buffer A (50 mM Tris-HCl, pH 7.5, containing 1 mM dithiothreitol, 150 mM NaCl, 
0.1% TritonX-100, and 10% glycerol). Then glutathione-immobilized beads in the same 
buffer were added to an equal volume of the above reaction mixture and incubated for 2 
h at 4°C. After extensive washing, the proteins that had bound to beads were used for 
GST pull-down experiments. 
 For preparation of non-tagged recombinant Xrpn10 proteins or Scythe Domain 
I and Domain II fragments, the beads were suspended in an appropriate volume of 
buffer A containing PreScission protease (Amersham Biosciences), and the mixture was 
incubated for 12 h at 4°C to allow the protease to cleave the GST-tag. The proteins thus 
formed were then used as purified Xrpn10 proteins. Purified non-tagged proteins and 
GST-fusion proteins coupled with beads were mixed, incubated, and precipitated, and 
the resulting pull-down samples were subjected to Western blotting with appropriate 
antibodies as indicated. 
 
RT-PCR 
 For RT-PCR analysis, Xenopus embryos were disrupted by treatment with 
TRIzol (Life Technologies, Inc., Gaithersburg, MD), and total RNAs were extracted. 
Five µg of total RNA was then reverse-transcribed with SUPERSCRIPT II reverse 
transcriptase (Life Technologies, Inc.) using random hexamers. Using the cDNA 
products as templates, xrpn10 cDNAs were amplified by PCR with primers specific for 
xrpn10a and xrpn10c. Twenty-five cycles for xrpn10a or 30 cycles for xrpn10c were 
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run with denaturation at 94°C for 1 min, annealing at 65°C for 1 min, and elongation at 
72°C for 5 min. 
 
Expression of proteins in Xenopus embryos 
 Full-length cDNAs for Xrpn10a, Xrpn10c and Scythe were subcloned into the 
RN3 vector (Lemaire et al., 1995), and the mRNAs were synthesized in vitro by 
mMESSAGEmMACHINE (Ambion Inc., Austin, TX). The synthesized mRNAs were 
dissolved in RNase-free water, and 5 ng of mRNAs was injected in a volume of 9.2 nL 
into a blastomer of 2-cell stage embryos of Xenopus embryos. Embryos were cultured in 
a 0.2 × MMR solution at 20°C. At the blastulae stage, each embryo was individually 
harvested, crushed in PBS, and centrifuged to collect the cytoplasm fraction. Samples of 
this fraction were used for immunoprecipitations with an anti-Flag antibody and 
subsequently subjected to Western blot analysis. 
 
Nucleotide sequences 
 The nucleotide sequence data reported in this paper appear in the DDBJ, 
EMBL and GenBank Nucleotide Sequence Databases with the following accession 
numbers: Xrpn10 genome (AB190306), Xrpn10a cDNA (AB190304), Xrpn10c cDNA 
(AB190305). 
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Results 
 
Identification of xrpn10c in Xenopus embryos 
 The mouse rpn10 gene is comprised of 10 exons, and specific retention of 
several introns generates multiple spliced isoforms, including at least five distinct forms, 
named Rpn10a to Rpn10e (Kawahara et al., 2000a). Comparison of the genomic 
sequences revealed identical exon-intron organizations of rpn10 genes in all of the 
vertebrates examined (Fig. 7A). These findings imply that the competence for all 
distinct forms of rpn10 alternative splicing is conserved among vertebrates. 
 Rpn10c, one of the spliced forms of the rpn10 gene, was originally isolated 
from mouse ES cells and has been detected in mouse embryonic tissues (Kawahara et 
al., 2000a). As a model system for further developmental analysis, I looked at rpn10 
family transcripts in the African clawed frog, Xenopus laevis, and found that the rpn10c 
homologue is adequately expressed in the developing Xenopus embryos. PCR-assisted 
cloning allowed us to isolate the full-length cDNA encoding the Xenopus counterpart of 
rpn10c as well as a universally expressed rpn10a homologue, and I designated these 
genes as xrpn10c and xrpn10a, respectively (Fig. 7B). Sequence alignment of Xrpn10a 
and Xrpn10c revealed that they have identical sequences in their N-terminal halves, 
including two UIM segments, whereas the C-terminal region varied greatly (Fig. 7B). 
The C-terminal region of Xrpn10c contains a unique sequence that shows no overall 
homology to the sequences of other known proteins except for its orthologues in 
vertebrates (Fig. 7B, C). In Xrpn10c-specific C-terminal extensions, I identified a 
relatively conserved amino acid stretch, and I tentatively designated this region as 
10c-box (Fig. 7C). The expression profile of xrpn10 family genes was analyzed by 
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reverse transcription-polymerase chain reaction (RT-PCR) using a set of primers 
corresponding to the specific sequences of either the xrpn10a or xrpn10c gene (Fig. 7D). 
The xrpn10a transcript was found to be expressed constitutively from unfertilized eggs 
to adult tissues, indicating its ubiquitous expression, as is the case with the mouse 
rpn10a. In contrast, using primers A and C, fragments of 580-bp were amplified 
exclusively from embryonic stages 15 to 25 and no detectable expression was observed 
in unfertilized eggs and earlier embryos. Sequence analysis of these fragments 
confirmed that the 580-bp band indeed corresponds to xrpn10c. Thus, xrpn10c was 
found to be a transcript whose expression is altered in a developmental stage-specific 
manner. 
 
Xrpn10c specifically binds to Scythe, a UBL protein 
 To explore the roles of Xrpn10c, I searched for a protein(s) that specifically 
interacts with Xrpn10c. Since it has been reported that several UBL domain proteins can 
interact directly with the C-terminal half of mammalian S5a/Rpn10a (Hiyama et al., 
1999; Walters et al., 2002), I cloned several UBL protein genes from a Xenopus cDNA 
library and examined their interactions with Xrpn10 family proteins. I confirmed that 
both XHR23B and XDRP1 (Funakoshi et al., 1999), Xenopus counterparts of yeast 
Rad23 and Dsk2, respectively, could bind equally to both Xrpn10a and Xrpn10c in a 
UIM domain-dependent manner (Fig. 8). In contrast, Scythe was exclusively 
co-immunoprecipitated with Xrpn10c, while there was no interaction between Xrpn10a 
and Scythe (Fig. 9). It has been reported that Scythe is composed of an N-terminal 
single UBL domain and a C-terminal BAG domain as well as intervening repetitive 
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sequences (Thress et al., 1998; Thress et al., 2001). These results indicate that Scythe is 
a UBL protein that specifically interacts with Xrpn10c. 
 Since both Xrpn10c and Scythe are proteins that are expressed in Xenopus 
embryos, I carried out an experiment to determine whether Xrpn10c can interact with 
Scythe in developing Xenopus embryos. I microinjected in vitro synthesized mRNA 
encoding Xrpn10c and Scythe into the fertilized eggs of X. laevis and harvested the 
embryos at the blastulae stage (stage 7). The mRNA injection resulted in production of 
corresponding proteins in the Xenopus embryos (Fig. 10A, input). It was found that 
Xrpn10c, but not Xrpn10a, specifically precipitated with Scythe (Fig.10A, IP), as was 
the case in extracts of COS7 cells (Fig. 9). These results indicate that Xrpn10c protein 
can associate with Scythe in the developing Xenopus embryos. I also found that the 
exogenously expressed Xrpn10c protein, as well as Xrpn10a, was incorporated into the 
endogenous 26S proteasome complex in living embryos, since immunoprecipitation 
with antibody against Rpt6, an ATPase subunit of the endogenous 26S proteasome, 
simultaneously co-precipitated Xrpn10c and Xrpn10a (Fig. 10B, IP). I do not know the 
reason why the incorporation of Flag-Xrpn10a seems to be much lower than that of 
Xrpn10c. As there are no good antibodies specific for Xrpn10c, it has not been possible 
to demonstrate the presence of endogenous Xrpn10c proteins in 26S proteasomes.  
 Using anti-Scythe antibody, it was found that there is no detectable binding of 
endogenous Scythe to proteasome at this early developmental stage (Fig. 10B, IP left 
lane). Only if Flag-Xrpn10c mRNA is injected, endogenous Scythe can be adequately 
co-immunoprecipitated with 26S proteasomes (Fig. 10B, IP center lane), but not if the 
Xrpn10a version is overexpressed (Fig. 10B, IP right lane). In the former case, the 
amount of Xrpn10c containing proteasome versus Xrpn10a proteasomes might be 
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increased significantly, whereas in the latter case, the putatively large population of 
Xprn10a proteasomes could stay unchanged or increase only slightly. All this is in favor 
for specific binding of Scythe to Xrpn10c and not to Xrpn10a in the context of the 26S 
proteasome components. 
 
Xrpn10c-specific region functions as a novel site for Scythe recognition 
 To identify the Scythe-binding site in Xrpn10c, I co-expressed a series of 
Flag-tagged Xrpn10c mutant proteins and T7-tagged Scythe (Fig. 11). I found that the 
C-terminal half of Xrpn10c was necessary for Scythe binding (Fig. 11A, D). 
Remarkably, mutational analysis revealed that neither the UIM1 nor the UIM2 domain 
is necessary for Scythe binding (Fig. 11B, D). These results indicate that Scythe 
interacts with Xrpn10c by a mechanism different from those in the cases of other known 
UBL proteins such as hHR23A/B. Further deletion analysis of Xrpn10c revealed that a 
segment containing the Xrpn10c-specific region was necessary and sufficient for Scythe 
binding (Fig. 11B, C, D). The most critical region for Scythe binding in Xrpn10c was 
the C-terminal region containing amino acid residues 331 to 339 (Fig. 11C, D), 
designated as 10c-box (Fig. 7C), the sequences of which are conserved across species, 
and deletion of this sequence largely abolished Scythe binding (Fig. 11B, C, D). To 
precisely evaluate the contribution of the 10c-box sequence for Scythe binding, I 
quantified the relative intensity of immunosignals of 10c-box-lacking forms of Xrpn10c 
compared to 10c-box-including forms. The signal of Xrpn10c (1-330) decreased more 
than 89% compared to that of (1-339). Similarly, the signal of (249-330) decreased 
more than 71% compared to that of (249-339), and the signal of (304-330) decreased 
more than 78% compared to that of (304-339). Consistent with the importance of the 
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10c-box sequence, a GST-fusion protein with the 10c-box consisting of nine amino 
acids could bind with Scythe as strongly as the full-length Xrpn10c (discussed later in 
Fig. 13B, C). These results indicate that the 10c-box is directly responsible for the 
interaction of Xrpn10c with Scythe. 
 
Novel tandem UBL domains of Scythe contribute to Xrpn10c binding 
 To identify the Xrpn10c-binding site in Scythe, I generated T7-tagged deletion 
mutants of Scythe protein and co-expressed them with Flag-tagged Xrpn10 in COS7 
cells. I found that a segment containing the N-terminal region (1-436) was sufficient for 
Xrpn10c binding, indicating that the BAG domain at the C-terminus of Scythe is not 
necessary for Xrpn10c binding (Fig. 12A, B). In good agreement with these in vivo 
observations, an in vitro GST pull-down assay using recombinant proteins suggests a 
direct interaction between Xrpn10c and N-terminal fragment of Scythe (Fig. 13A). 
Xrpn10c, but not Xrpn10a, was co-precipitated with GST-Scythe (1-436) (the 
N-terminal 436-amino acid fragment of Scythe; designate as N436), while neither 
GST-Scythe (801-1113) (the C-terminal 313-amino acid fragment of Scythe; designate 
as C313) nor GST alone precipitated Xrpn10c (Fig. 8A), indicating that the N-terminal 
region of Scythe is required for its direct binding with Xrpn10c. 
 Unexpectedly, deletion of N-terminal UBL domain (86 amino acids) from 
full-length and N-terminal 436-amino acid fragment of Scythe did not abolish 
Xrpn10c-binding. My further analysis revealed that, within N436 fragment, there are 
two independent segments called Domain I (Scythe 1-214) and Domain II (Scythe 
215-436) that can bind with Xrpn10c in vivo (Fig. 12A, B). Results of in vitro GST 
pull-down assays using recombinant proteins also suggest that Xrpn10c or its 10c-box 
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peptide directly interact with the fragment of either Domain I (Fig. 13B) or Domain II 
(Fig. 13C) of Scythe protein. Domain I contains a typical UBL domain (amino acid 
residues 7-81; 38.2% identity and 64.5% similarity to ubiquitin) as reported by Thress et 
al. (Thress et al., 1998) (see Fig. 14A) in its N-terminus, and this UBL sequence in the 
Domain I was essential for Domain I to bind with Xrpn10c (Fig. 12A, B). On the other 
hand, no ubiquitin homology had been reported in the region corresponding to the 
Domain II. However, my close inspection of the primary sequence revealed that 
N-terminal half of Domain II indeed contains an additional sequence with a homology 
to ubiquitin (amino acid residues 257-323; 26.3% identity and 46.1% similarity to 
ubiquitin), and I designate this region here as UBL2 (Fig. 14A. C). Note that I 
designated the UBL motif in the N-terminus of Domain I as UBL1 to distinguish it from 
UBL2. It is important to note that the region of UBL2 is essential for Domain II to 
interact with Xrpn10c (Fig. 14B, C). Thus, the results of my analysis suggested the 
presence of a novel second ubiquitin homology sequence that had not been previously 
identified and show that ubiquitin homology domains in both Domain I and Domain II 
are involved in targeting of Scythe to Xrpn10c in vivo. These results indicate that Scythe 
is a novel protein that contains functional tandem ubiquitin homology sequences in its 
N-terminal region. 
 
Tandem UBL domains contributes to the function of Scythe 
 Scythe was originally identified as a novel anti-apoptotic protein, though the 
function of its UBL domain remains entirely obscure (Thress et al., 1998). In fact, 
expression of the N-terminal truncated form of Scythe (∆N100) lacking UBL1 did not 
have any effect on normal Xenopus development. To address the significance of my 
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finding that Scythe contains unique tandem ubiquitin homology domains that are 
required for Xrpn10c interaction, I synthesized translatable mRNAs encoding T7-tagged 
Scythe and a series of its UBLs-truncated mutant proteins, and then injected the 
respective mRNAs into a blastomere of 2-cell stage embryos. 
 It has been reported that the C312 fragment of Scythe is a potent, 
Reaper-independent inducer of apoptosis in a Xenopus cell-free system (Thress et al., 
1998). Recombinant Scythe C312 protein induced apoptotic nuclear fragmentation and 
caspase DEVDase activation with a time course similar to that for Reaper-induced 
apoptosis in the extracts (Thress et al., 1998). I confirmed these results by my in vivo 
assay by injecting mRNA encoding Scythe C312 into a blastomere of 2 cell-stage 
embryos, which resulted in complete impairment of normal tadpole development (Fig. 
15A). The expression of full-length Scythe (FL) did not influence normal development 
(Fig. 15). Neither expression of ∆UBL1 (in which amino acid residues 7-81 had been 
deleted from the full length of Scythe) nor that of ∆UBL2 (in which amino acid residues 
258-324 had been deleted) caused detectable developmental abnormality (Fig. 15A). In 
contrast, the expression of Scythe protein lacking both UBL1 and UBL2 (∆UBL1, 2; 
simultaneous deletion of amino acid residues 7-81 and 258-324) triggered inappropriate 
embryonic development and greatly reduced the rate of normal tadpole development 
(Fig. 15). Embryos expressing Scythe (∆UBL1, 2) underwent rounds of normal cell 
division during their blastula stage, but they progressively deviated from normal 
morphogenesis thereafter and failed to develop into normal tail bud embryos. These 
results suggest that the UBL1 and UBL2 domains of Scythe are redundantly involved in 
the control of appropriate progression of embryogenesis during the course of Xenopus 
development.  
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Discussion 
 
 In this study, I found that proteasomal Xrpn10c subunit physically associates 
with Scythe in Xenopus embryos, while there is no interaction between Scythe and 
Xrpn10a, a ubiquitous form of Rpn10 splicing variants (Kawahara et al., 2000a). 
Xrpn10c has a unique extension at the C-terminal side. I found that an Xrpn10c-specific 
C terminal sequence is required and sufficient for Scythe binding. The essential region 
of Xrpn10c for Scythe binding is amino acid residues 331-339, and I called this motif 
10c-box. Although 10c-box does not have obvious sequence similarity to other UBL 
binding domains, such as UIM, I concluded that Xrpn10c containing the 10c-box 
functions as a Scythe binding receptor. I suggest that the region containing the 10c-box 
is a novel candidate for the UBL protein-binding domain of the 26S proteasome. It has 
not yet been determined whether this motif can interact with other known UBL proteins 
in general. Alternatively, it is plausible that the 10c-box is a binding motif specific to 
tandem ubiquitin homology domain of Scythe, because XHR23B and XDRP1 did not 
interact with 10c-box (Fig. 8).  
 In yeast, it has been reported that UBL domains of Rad23 and Dsk2 bind the 
leucine-rich-repeat (LRR)-like region in Rpn1 of the 26S proteasome (Elsasser et al., 
2002; Seeger et al., 2003), indicating that Rpn1 is a general receptor for the UBL 
domain. In addition to Rpn1, UIMs of the Rpn10 subunit have also been identified as 
alternative acceptor sites for UBL domains of hHR23A/B, PLIC and Parkin in 
vertebrates (Hiyama et al., 1999; Sakata et al., 2003). These results collectively indicate 
that there are multiple acceptor sites for specific classes of UBL proteins in the 26S 
proteasome complex. The existence of distinct binding sites for UBL proteins on the 
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26S proteasome might ensure simultaneous interactions between several UBL proteins 
and the 26S proteasome, preventing competition among them. In addition, it is of note 
that mammalian Rpn10 gene generates multiple variants through alternative splicing, 
which may contribute to the achievement of functional diversity of 26S proteasomes 
with their respective isoforms. In this regard, it is interesting that Rpn10c exhibits a 
unique interaction with Scythe. The unanswered question is whether different 
physiological binding partners have varying receptor preferences and, if so, what 
features of substrates might predispose them to a particular docking mode. Thorough 
analysis of changes of proteasome function in mutants that possess defects in the 
respective interactions will be necessary to elucidate this point. 
 Scythe was originally identified as a binding protein of Reaper, a potent 
apoptotic inducer, and was suggested to inhibit Reaper-induced apoptosis in Xenopus 
egg extracts (Thress et al., 1998). It has been reported that the BAG domain of Scythe 
regulates Hsp70-mediated protein folding and that Scythe-mediated inhibition of Hsp70 
is reversed by Reaper (Thress et al., 2001). Although the role of the N-terminal UBL 
domain has not been elucidated, it has been reported that the addition of the C-terminal 
fragment of Scythe (Scythe C312) in Xenopus egg extracts induced Reaper-independent 
apoptosis (Thress et al., 1999; Thress et al., 1998), implying the potential role of Scythe 
N-terminal half in the regulation of apoptosis. In this paper, I identified two distinct 
domains in the N-terminal region of the Scythe, Domain I and Domain II, capable of 
binding Xrpn10c redundantly. Domain I contains a typical UBL sequence (designated 
here UBL1), as reported by Thress et al. (Thress et al., 1998), and I found that deletion 
of this UBL1 region abolished the binding ability of Domain I for Xrpn10c. Domain II 
also contained a UBL2 sequence with similarity to ubiquitin, which had not been 
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reported previously. UBL2 is comprised of 67 amino acid residues, displaying 46% and 
41% overall similarity to ubiquitin and UBL1, respectively (Fig. 9A), and this region is 
well conserved in the mammalian homologue of Scythe called BAT3. I found that 
UBL2 is an essential sequence within Domain II for the association with Xrpn10c. Thus, 
it can be concluded that Scythe is a novel protein with at least two tandem ubiquitin 
homology domains, UBL1 and UBL2. It is of note that these ubiquitin homology 
domains of Scythe did not interact with the UIM of Rpn10 and Rpn1 subunit of 26S 
proteasome, differing from other UBL-containing proteins. Unexpectedly, I found that 
both UBL1 and UBL2 domains are necessary but not themselves sufficient for 
interaction with Xrpn10c. This finding indicates that both domains require the 
respective additional C-terminal regions in Domain I and Domain II, respectively, to 
interact with Xrpn10c and implies that the UBL domains, together with their additional 
C-terminal sequences, form novel structures that associate with a domain unrelated to 
UIM or UBA domains. Further structural analyses are in progress. 
 Scythe belongs to a family of BAG proteins (Takayama and Reed, 2001; 
Takayama et al., 1995). It has been reported that BAG-1 is the physical link between the 
Hsc70/Hsp70 chaperone system, ubiquitination machineries and the proteasome 
(Alberti et al., 2002; Demand et al., 2001; Luders et al., 2000; Takayama et al., 1997). In 
a way similar to the case with BAG-1, it is possible that Scythe links the proteasomes to 
chaperones. Indeed, the UBL regions of Scythe are associated with the Xrpn10c subunit 
of the 26S proteasome, while the C-terminal BAG domain combines the molecular 
chaperones Hsp70 (Thress et al., 1999; Thress et al., 2001). My preliminary analysis 
indicated that Scythe was co-precipitated with Xchip, a Xenopus homologue of the 
chaperone-dependent E3 ubiquitin ligase CHIP (C-terminus of Hsc70-interacting 
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protein) (Murata et al., 2001; Wiederkehr et al., 2002). My findings imply that Xrpn10c 
and Scythe may act as novel physical coupling factors to form a multi-complex 
comprising the 26S proteasome, the molecular chaperone Hsp70 and the E3 ubiquitin 
ligase. Furthermore, it was reported that the UBL/UBA domain proteins Rad23 and 
PLIC act as adaptor molecules in the control of post-ubiquitination events (Elsasser et 
al., 2002; Kleijnen et al., 2000). My results imply that UBL/BAG adaptor proteins 
recognize chaperone substrates and deliver them to the proteolytic machinery. Although 
such protein(s) of the apoptotic pathway is currently obscure, the results of the present 
study suggest that substrate recognition occurs by temporally and spatially regulated 
expression of Xrpn10 isoforms in collaboration with specific UBL proteins. Thus, 
targeting of substrates to the 26S proteasome might be regulated by multiple 
mechanisms. Accordingly, further studies are required to clarify the 
substrate-recognition diversity of UBL proteins and Rpn10 family proteins. 
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Figures 
 
Fig. 7. Identification of the xrpn10c gene from Xenopus.  
(A) Physical maps of genomic organization of the Xenopus rpn10 gene (xrpn10). The 
scale shows the length of 1 kbp. Exons are indicated by filled boxes and numbered from 
1 to 10. The exon-intron structure of xrpn10 is identical to that of the mouse rpn10 gene 
(mrpn10). The alternatively retained intron for generating xrpn10c is marked 
“alternative spliced region” (for details, see Kawahara et al., 2000). (B) Schematic 
representation of the structures of Xrpn10a and Xrpn10c proteins deduced from cDNA 
sequences. The ubiquitin-interacting domains (UIM1 and UIM2) and Rpn10c-specific 
region are indicated by colored boxes. (C) Alignment of C-terminal sequences of 
Rpn10c proteins from Xenopus (Xrpn10c), rat (Rrpn10c) and mouse (Mrpn10c). The 
conserved region (amino acid residues 331-340) is indicated by the open box and 
designated ‘10c-box’. (D) Expression of xrpn10c mRNA is developmentally regulated. 
PCR primers were designed for the conserved sequence in UIM1 (primer A), 
xrpn10a-specific region (primer B) and xrpn10c-specific region (primer C).  RT-PCR 
was performed using the mRNA derived from embryos of the respective stages of 
development (right panel).  
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Fig. 8. Xrpn10a and Xrpn10c interact with XHR23B and XDRP1 in a UIM 
domain-dependent manner.  
Various deletion mutants of Flag-tagged Xrpn10a and Xrpn10c were expressed in COS7 
cells. Cell extracts were mixed with GST protein or GST-fusion proteins of XHR23B 
and XDRP1, and the mixture was subjected to an in vitro GST pull-down assay with 
glutathione-Sepharose beads. The precipitants were immunoblotted with anti-Flag 
antibody. UIM1 (N5), UIM2 (N5) and UIM1,2 (N5) indicate site-directed substitution 
of the core sequences of UIM1, UIM2 and both to successive five Asn residues 
(LALAL for UIM1 and IAYAM for UIM2 to NNNNN, respectively). Xrpn10a,c (1-312), 
which retains UIM1 and UIM2 but lacks variable C-terminal region, interacted with 
XHR23B and XDRP1 while Xrpn10c ∆196-307, which retains the 10c-box but lacks 
UIM1 and UIM2, did not bind to XHR23B and XDRP1. 
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Fig. 9. Xrpn10c, but not Xrpn10a, interacts with Scythe. 
T7-tagged Scythe and Flag-tagged Xrpn10a or Xrpn10c were expressed in COS7 cells 
at the indicated combinations. Cell extracts were immunoprecipitated with anti-Flag M2 
agarose beads, and the precipitates were immunoblotted with anti-T7 and anti-Flag 
antibodies. 
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Fig. 10. Xrpn10c interacts with Scythe and the 26S proteasome in Xenopus 
embryos. 
Synthetic mRNAs for Flag-Xrpn10a and Xrpn10c were microinjected into fertilized 
eggs of X. laevis, and the embryos were harvested at the blastulae stage for 
immunoprecipitation analysis. (A) T7-tagged Scythe was co-precipitated with 
Flag-tagged Xrpn10c but not with Xrpn10a from Xenopus embryonic extracts. (B) Both 
Flag-tagged Xrpn10a and Xrpn10c were co-immunoprecipitated with the endogenous 
proteasomes by antibody against Rpt6 ATPase subunit of the 26S proteasome. 
Endogenous Scythe protein was also co-precipitated by antibodies against Rpt6 and 20S 
proteasome complex in the condition of Xrpn10 expression. 
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Fig. 11. Xrpn10c interacts with Scythe via Rpn10c-specific region. 
(A) T7-tagged Scythe and various deletion mutants of Flag-tagged Xrpn10 were 
expressed in COS7 cells as indicated. Cell extracts were immunoprecipitated with 
anti-Flag M2 agarose beads, and the precipitates were immunoblotted with anti-T7 and 
anti-Flag antibodies. FL represents the full-length form of either Xrpn10a or Xrpn10c. 
(B) The ubiquitin-interacting motifs (UIM1 and UIM2) of Xrpn10c are dispensable for 
Scythe interaction. ∆UIM1 indicates specific elimination of amino acid residues 
196-241, and ∆UIM2 indicates specific elimination of amino acid residues 263-307. 
UIM1-N5 and UIM2-N5 indicate site-directed substitution of the core sequences of 
UIM1 and UIM2 to successive five Asn residues (LALAL for UIM1 and IAYAM for 
UIM2 to NNNNN, respectively). The results of the experiment on the effects of 
continuous C-terminal deletion of Xrpn10c (1-347, -339, -330, -321) indicated that 
Xrpn10c (1-339) is sufficient for Scythe binding. (C) Flag-tagged Scythe and various 
regions of GFP-tagged Xrpn10c were co-expressed in COS7 cells as indicated. The cell 
extracts were immunoprecipitated with anti-Flag M2 agarose beads, and the precipitates 
were immunoblotted with anti-GFP antibody. (D) Schematic representation of various 
deletion mutants of Xrpn10c. The 10c-box is indicated by the open box. Successful 
Scythe interactions with Xrpn10 fragments are represented as (+) and failures are 
represented as (-). 
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Fig. 12. Xrpn10c interacts with two independent N-terminal domains of Scythe. 
(A) Flag-tagged Xrpn10c and various deletion constructs of T7-tagged Scythe were 
expressed in COS7 cells as indicated. Cell extracts were immunoprecipitated with 
anti-Flag M2 agarose beads, and the precipitates were immunoblotted with anti-T7 and 
anti-Flag antibodies. Note that open arrows denote the mutant Scythe signal that did not 
co-precipitate with Flag-Xrpn10c. HC and LC represent protein bands of heavy- and 
light-chain of IgG, respectively. (B) Schematic representation of various deletion 
mutants of Scythe. Note that there are two independent Xrpn10c-binding domains in the 
N-terminus of Scythe (Domain I and Domain II). Xrpn10c-binding with Scythe 
fragments is represented as (+) and its failure is represented as (-) on the right.  
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Fig. 13. Xrpn10c or its 10c-box fragment directly binds with the N-terminal 
fragments of Scythe in vitro. 
(A) Bacterially-expressed GST-fusion proteins as indicated were purified and mixed 
with bacterially-expressed non-tagged Xrpn10a or Xrpn10c, and the mixture was 
subjected to an in vitro GST pull-down assay with glutathione-Sepharose beads. 
Precipitants were immunoblotted with an anti-Xrpn10 antibody that recognizes the 
N-terminal region of both Xrpn10a and Xrpn10c. GST that was fused with the 
N-terminal 435-a. a. fragment of Scythe and GST that fused with the C-terminal 313-a. 
a. fragment of Scythe were designated as GST-Scythe (N435) and GST-Scythe (C313), 
respectively. GST-XHR23B was used as a positive control. (B, C) Bacterially-expressed 
GST-fusion proteins as indicated were mixed with bacterially-expressed non-tagged 
Scythe Domain I (B) or Domain II (C), and the mixture was subjected to an in vitro 
GST pull-down assay. Precipitants were immunoblotted with anti-Scythe antibodies. 
GST that was fused with the 10c-box fragment (9 a. a.) was designated as GST-10c-box. 
Note that the molecular masses of Scythe Domain I and Domain II correspond to 32 
kDa and 36 kDa, respectively. Asterisks indicate partial truncated forms of Xrpn10c. 
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Fig. 14. Tandem ubiquitin homology domains contribute to Xrpn10c binding of 
Scythe. 
(A) Multiple alignments of ubiquitin homology domains of Scythe, UBL1 (7-81), UBL2 
(257-323) and ubiquitin. Amino acid residues that are conserved in all three sequences 
are shown by closed boxes, and those that are conserved in two sequences are shown by 
shaded boxes. (B) Flag-tagged Xrpn10c and various deletion constructs of T7-tagged 
Scythe Domain II were expressed in COS7 cells as indicated. Cell extracts were 
immunoprecipitated with anti-Flag M2 agarose beads and subsequently blotted with 
anti-T7 antibody. (C) Schematic representation of deletion constructs of Scythe Domain 
I and II. UBL1 and UBL2 are indicated by closed boxes. Note that ubiquitin homology 
region of Domain I and II are required but not sufficient for Xrpn10c-binding. 
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Fig. 15. UBL1 and UBL2 domains of Scythe are redundantly required for the 
appropriate development of Xenopus embryos. 
Synthetic mRNA encoding Flag-tagged Scythe and its variant proteins were 
microinjected into Xenopus embryos. (A) Ectopic expression of T7-tagged C-terminal 
312 a. a. fragment of Scythe (designated as C312) as a positive control resulted in 
complete elimination of normal tadpole development of injected Xenopus embryos, 
while that of full-length Scythe (FL) (as a negative control) did not influence normal 
development. Neither the expression of ∆UBL1 nor that of the ∆UBL2 form of Scythe 
caused detectable developmental abnormality. In contrast, the expression of Scythe 
protein lacking both UBL1 and UBL2 (∆UBL1, 2) greatly reduced the rate of tadpole 
development. Data shown in A represent the mean ±SD of the indicated number of 
embryos (upper panel). Extracts from an each embryo were probed with anti-T7 
antibody to verify the expression of each form of Scythe (lower panel). (B) Schematic 
representation of Scythe and its mutant derivatives that were expressed in Xenopus 
embryos. UBL and BAG domains are indicated by closed and shaded boxes, 
respectively.  
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General Discussion 
  
79 
 
 It has been well recognized that the 26S proteasome system plays an important 
role in the degradation of the majority of intracellular proteins in eukaryotic cells 
(Collins and Goldberg, 2017). The function of each subunit of the 26S proteasome, 
however, has not been fully characterized. Through my studies, I focused on Rpn10, a 
regulatory subunit of the 26S proteasome, to shed the light on a molecular function of 
Rpn10 in vertebrates.  
 I clarified the genomic organization of Rpn10 gene in lower vertebrates 
Oryzias latipes (Japanese rice fish) and Xenopus laevis (African clawed frog), and 
provided evidence for the generation of Rpn10 isoforms in an alternative 
splicing-manner among vertebrates. Although this was not discussed in the Chapter 1 
because my primary object of the study was to show the genomic organizations of the 
vertebrate Rpn10, I also revealed that the Rpn10 gene of Ciona intestinalis (ascidian) is 
comprised of 7 exons, and retains the exon-intron junctions which potentially generate 
Rpn10 isoforms corresponding to mouse Rpn10c and Rpn10d (Fig. 16). My study on 
the genomic organization of Rpn10 gene was mostly achieved by complicated 
sequential PCR strategy in combination with degenerate PCR, nested PCR, and 
conventional PCR techniques. On the other hand, the recent advances of 
high-throughput sequencing technologies and public genomic databases have enabled 
me to examine Rpn10 genes of a wide variety of organisms. Given this situation, I 
searched for genomic structures of Rpn10 of additional organisms in databases to raise 
the confidence levels of the findings established by my study. I investigated several 
vertebrates including wolf (Canis lupus), chicken (Gallus gallus), zebrafish (Danio 
rerio), and several eukaryotic protists (Tetrahymena thermophila, Paramecium 
tetraurelia, and Trypanosoma brucei), and plants (Arabidopsis thaliana and Oryza 
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sative) at the NCBI Gene Database (https://www.ncbi.nlm.nih.gov/gene/) or elsewhere. 
This investigation indicated that the positions of the exon-intron junctions and the 
length of each exon are similar between vertebrates and plants but different in 
eukaryotic protists as in yeast, nemotode, and fruit fly. This is consistent with the 
findings brought up from my study discussed in the Chapter 1 in details, although 
sequencing analysis is essential to completely validate the observations from database 
information. Collectively, these findings indicate that Rpn10 molecule might have 
acquired complexities generated by alternative splicing at its C-terminal stretch through 
evolution to meet the requirement for expanded diversity of ubiquitin-mediated protein 
degradation. 
 I also elucidated a specific function of one of the Rpn10 isoforms, Rpn10c for 
the first time. I revealed that Xrpn10c is a Scythe-binding protein and Scythe has 
tandem UBL domains that are essential for the interaction with Xrpn10c. It was also 
indicated by my study that the tandem UBL domains of Scythe are redundantly 
implicated in the embryogenesis during Xenopus development. These findings clearly 
show the significance of Rpn10c and provide the first evidence that shows N-terminal 
tandem domains of Scythe act as essential regions linking the ubiquitin/proteasome 
machinery to the control of Xenopus embryonic development. Based on my studies, 
Minami et al. searched for a novel Scythe-binding protein from Xenopus embryo and 
identified XEF1AO (Minami et al., 2007), which has been reported as a potential 
apoptotic inducer in vertebrates (Kato et al., 1997; Ruest et al., 2002), and showed that 
Scythe regulates apoptosis through modulation of ubiquitin-mediated degradation of 
XEF1AO. This is a consistent finding with my study and would suggest a potential role 
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of Xrpn10c-specific proteasome in the regulation of apoptosis during Xenopus 
embryogenesis, although this might still be a preliminary assumption at this stage. 
 As mentioned in the General Introduction, the ubiquitin proteasome pathway is 
conserved among eukaryotes. It was well studied and shown that most of deletion or 
nonfunctional mutants of 26S proteasome subunits are lethal in yeast (Tanaka, 2009), 
suggesting the 26S proteasome is indispensable for cell survival in eukaryotes. 
Although knockout studies of the 26S proteasome in vertebrates are few, it was reported 
that Psmc3 (Rpn5) and Psmc4 (Rpn3)-deficient mice are embryonic lethal, suggesting 
that the 26S proteasome plays an essential role in development and embryogenesis in 
mammals (Sakao et al., 2000). It was also shown that neuron-specific Psmc1 
(Rpn2)-knockout mice exhibit 26S proteasomal dysfunction and neurodegeneration, 
indicating that the 26S proteasome is essential for normal neurodevelopment as well 
(Bedford et al., 2008). In addition, although yeast Rpn10 mutants are vulnerable to 
stress but not lethal (van Nocker et al., 1996b; Wilkinson et al., 2000), it has been 
reported that Rpn10 KO mice shows an embryonic lethality (Hamazaki et al., 2007). 
This is a consist observation with my results which indicated that Rpn10 plays an 
important role in the embryogenesis in Xenopus. It was also shown by Hamazaki et al. 
that mice expressing the N-terminal portion of Rpn10, which contains VWA domain but 
lacked UIMs exhibited embryonic lethality. These observations suggest that Rpn10 is 
indispensable for survival and development at least in mice, and its UIMs have distinct 
roles in mammals from yeast, as was indicated by my studies. However, Hamazaki et al. 
also showed that Rpn10a knock-in (KI) mice, which exclusively express Rpn10a (i.e. 
the constitutive type of Rpn10) and do not express other Rpn10 isoforms, are born 
normally at Mendelian frequency, suggesting that Rpn10b-to-Rpn10e isoforms are 
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dispensable for mouse embryogenesis. This observation could bring up a question if 
Rpn10 isoforms are important in frogs but this is not the case for mice, even though the 
experimental settings were completely different from those in my study. This potential 
difference between mice and frogs can be explained simply by species difference or by 
compensatory mechanisms in the case of Rpn10 KI mice. Although they showed that 
some of the proteasome-related protein levels were comparable between wild-type and 
Rpn10a KI mice, it is likely that the other proteins (e.g. substrate proteins, regulatory 
proteins) which they did not examine are up- or down-regulated to adapt to the 
environment and maintain protein homeostasis as Rpn10a KI mice lack 
Rpn10b-to-Rpn10e from the beginning of the life. In contrast, in the case of my study, 
aberrant forms of Scythe that lacked both UBLs and were exogenously expressed after 
fertilization and in the middle of embryogenesis, the timing of which Xrpn10c plays a 
crucial role in, caused the dysregulation of protein degradation by the Xrpn10c-specific 
26S proteasome. To address possible functions of Rpn10 splicing variants in mouse 
embryogenesis, it would be interesting to examine the knockdown of each Rpn10 
isoform mRNA during development stages. This is expected to be conducted in the 
future studies. 
 Physiological roles of Scythe have been more and more elucidated since I 
published my studies. Scythe is currently considered to be essential for the quality 
control of protein biogenesis as a chaperone molecule in association with CHIP and 
Hsp70 as well as play important roles in antigen presentation, the T-cell response, and 
apoptosis (Binici and Koch, 2014; Kawahara et al., 2013). Although I focused my 
research on the role of Rpn10 isoforms in the embryonic development because they 
were originally subcloned from embryonic cDNAs, it is possible that at least some of 
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the Rpn10 isoforms are expressed in adults as well and play some roles in the regulation 
of various physiological functions in which Scythe is implicated. In addition, it is likely 
that there are other Rpn10c-binding proteins than Scythe. These questions are expected 
to be addressed in future studies. 
 In conclusion, my first study suggests that vertebrate Rpn10 molecule has 
acquired the unique diversity which is not observed in other proteasome subunits, 
presumably to meet the requirement for expanded role of the 26S proteasome in protein 
degradation through evolution. In addition, my second study provides clear evidence 
linking the Rpn10c to the control of embryonic development. As embryogenesis is the 
active process that generates new cells and tissues within a short period of time, it may 
require another protein degradation mechanism by Rpn10 isoforms to enhance the 
activity and substrate selectivity of the 26S proteasome. It is highly valuable that my 
studies shed the light on a novel substrate recognition mechanism of the 26S 
proteasome by an Rpn10 splicing variant and its role in normal embryonic development. 
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Fig. 16. Physical maps of genomic organization of yeast, ascidian, fish, frog, and 
mouse Rpn10 genes.  
The scale shows the length of 1 kbp. Exons are indicated by solid boxes and numbered 
from 1 to 10. Yeast, Saccharomyces cereviciae; Ascidian, Ciona intestinalis; Japanese 
rice fish, Oryzias latipes; African clawed frog, Xenopus laevis; and mouse, Mus 
musculus. 
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